Stay updated on IGN002 Clinical Trial in Refractory NHL

Sign up to get notified when there's something new on the IGN002 Clinical Trial in Refractory NHL page.
Latest website image capture
Clouds background image

Latest updates to the IGN002 Clinical Trial in Refractory NHL page

  1. Check
    2 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed from the content. Additionally, a note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    2%
    Check dated 2025-07-04T03:53:13.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-19T19:24:45.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:03:05.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T05:48:44.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T13:48:31.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed descriptions of a Phase 1 extension study for the IGN002 treatment for Non-Hodgkin Lymphoma, while adding information about the study's collaborators and a revision number update.
    Difference
    34%
    Check dated 2025-04-16T01:41:59.000Z thumbnail image

Stay in the know with updates to IGN002 Clinical Trial in Refractory NHL

Enter your email address, and we'll notify you when there's something new on the IGN002 Clinical Trial in Refractory NHL page.